EUVIMEDEUVIMED entdecken
Crossref

Histopathological and Serum Biomarkers Analyses in MRONJ due to Periodontal Disease in Rats: Comparison of Zoledronic Acid and Denosumab

Ceren Çoşkun, Revan Koca Ünsal, Merva Soluk Tekkeşin, Faruk Çelik, Hayriye Ergen, Şakir Zeybek, Kıvanç Kayhan, Meral Ünür

Experimed · 2023

DOI: 10.26650/experimed.1190912 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimed, 2023. Verfasst von Ceren Çoşkun und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Çoşkun, C., Ünsal, R. K., Tekkeşin, M. S., Çelik, F., Ergen, H., Zeybek, Ş., Kayhan, K., & Ünür, M. (2023). Histopathological and Serum Biomarkers Analyses in MRONJ due to Periodontal Disease in Rats: Comparison of Zoledronic Acid and Denosumab. Experimed. https://doi.org/10.26650/experimed.1190912

Vancouver

Çoşkun C, Ünsal RK, Tekkeşin MS, Çelik F, Ergen H, Zeybek Ş, et al. Histopathological and Serum Biomarkers Analyses in MRONJ due to Periodontal Disease in Rats: Comparison of Zoledronic Acid and Denosumab. Experimed. 2023. doi:10.26650/experimed.1190912

BibTeX
@article{okun2023,
  author = {Çoşkun, Ceren and Ünsal, Revan Koca and Tekkeşin, Merva Soluk and Çelik, Faruk and Ergen, Hayriye and Zeybek, Şakir and Kayhan, Kıvanç and Ünür, Meral},
  title = {Histopathological and Serum Biomarkers Analyses in MRONJ due to Periodontal Disease in Rats: Comparison of Zoledronic Acid and Denosumab},
  journal = {Experimed},
  year = {2023},
  doi = {10.26650/experimed.1190912}
}
Kostenlos starten →